4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Shanghai Junshi Biosciences Co., Ltd. (1877) operates in the Biotechnology industry and is headquartered in Shanghai, China with about 3,055 employees. Its market capitalization is roughly HK$19 billion. In the fiscal year ended 2025-12-31, 1877 reported CNY 2.5B in revenue and (CNY 841M) in net income.
Shanghai Junshi Biosciences Co., Ltd., a biopharmaceutical company, engages in the discovery, development, and commercialization of various drugs in China.
Interactive charts & full statements → Open the 1877 valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CNY 2.5B | CNY 1.9B | CNY 1.5B | CNY 1.5B | — |
| Gross Profit | CNY 2.0B | CNY 1.4B | CNY 835M | CNY 927M | — |
| Operating Income (EBIT) | (CNY 925M) | (CNY 1.3B) | (CNY 2.5B) | (CNY 2.7B) | — |
| Net Income | (CNY 841M) | (CNY 1.3B) | (CNY 2.3B) | (CNY 2.4B) | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 12.4B | CNY 10.8B | CNY 11.4B | CNY 12.6B | — |
| Total Liabilities | CNY 6.3B | CNY 4.8B | CNY 4.0B | CNY 2.8B | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 1877 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms